EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating bowel preparation tolerability in IBD: a phase 3 post-hoc comparison of mannitol and PEG-ASC

Gian Eugenio Tontini, Alessandro Rimondi, Flavio Caprioli, Giovanni Aldinio, Luca Pastorelli, Franco Radaelli, Cristiano Spada, Maurizio Vecchi

Frontiers in Gastroenterology · 25.08.2025 · 4

DOI: 10.3389/fgstr.2025.1630479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 25.08.2025. Verfasst von Gian Eugenio Tontini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bowel preparation is a significant challenge for patients undergoing colonoscopy, especially in Inflammatory Bowel Disease (IBD) patients. Oral mannitol (OM), an ultra-low-volume, single-dose osmotic laxative with a sweet taste, could improve patient tolerability. We performed a post-hoc analysis of the phase 3, multicentre, randomized, endoscopist-blinded SATISFACTION trial to compare same-day OM versus standard split-dose 2L polyethylene glycol plus ascorbate (PEG-ASC) for bowel preparation in IBD patients. Fifty-five IBD patients (24 OM, 31 PEG-ASC) were assessed for bowel cleansing efficacy, endoscopic outcomes, safety, and patient satisfaction. OM demonstrated superior tolerability, including ease of use (88% vs . 71%), taste satisfaction (75% vs . 6%), and willingness to reuse (96% vs . 71%). OM also reduced intake duration (32 vs . 107 minutes) and time to evacuation (57 vs . 91 minutes), with comparable efficacy, cleansing quality, and safety. In conclusion, same-day OM preparation enhances satisfaction and adherence in IBD patients, offering a safe, effective alternative to standard protocols.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseasebowel preparationcolonoscopyinflammatory bowel diseaseoral mannitolpatient tolerabilitypolyethylene glycolulcerative colitis

Autor:innen und Institutionen

  • Department of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.
  • Gastroenterology and Endoscopy Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Royal Free Unit for Endoscopy, Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Department of Health Sciences, University of Milan, Milan, Italy.
  • Gastroenterology Unit, Valduce Hospital, Como, Italy.
  • Digestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Zitieren

APA

Tontini, G. E., Rimondi, A., Caprioli, F., Aldinio, G., Pastorelli, L., Radaelli, F., Spada, C., & Vecchi, M. (2025). Evaluating bowel preparation tolerability in IBD: a phase 3 post-hoc comparison of mannitol and PEG-ASC. Frontiers in Gastroenterology, 4. https://doi.org/10.3389/fgstr.2025.1630479

Vancouver

Tontini GE, Rimondi A, Caprioli F, Aldinio G, Pastorelli L, Radaelli F, et al. Evaluating bowel preparation tolerability in IBD: a phase 3 post-hoc comparison of mannitol and PEG-ASC. Frontiers in Gastroenterology. 2025;4. doi:10.3389/fgstr.2025.1630479

BibTeX
@article{Tontini2025,
  author = {Tontini, Gian Eugenio and Rimondi, Alessandro and Caprioli, Flavio and Aldinio, Giovanni and Pastorelli, Luca and Radaelli, Franco and Spada, Cristiano and Vecchi, Maurizio},
  title = {Evaluating bowel preparation tolerability in IBD: a phase 3 post-hoc comparison of mannitol and PEG-ASC},
  journal = {Frontiers in Gastroenterology},
  year = {2025},
  volume = {4},
  doi = {10.3389/fgstr.2025.1630479}
}
Kostenlos starten →